Literature DB >> 28716249

High risk of early conversion to multiple sclerosis in clinically isolated syndromes with dissemination in space at baseline.

Lorenzo Gaetani1, Fulvia Fanelli2, Ilenia Riccucci1, Paolo Eusebi1, Paola Sarchielli1, Carlo Pozzilli2, Paolo Calabresi3, Luca Prosperini2, Massimiliano Di Filippo4.   

Abstract

INTRODUCTION: Multiple sclerosis (MS) usually presents at onset with a clinically isolated syndrome (CIS). According to 2010 McDonald criteria, a diagnosis of MS can be made if CIS patients satisfy clinical/MRI criteria of both dissemination in time (DIT) and space (DIS).
OBJECTIVE: The aim of this study was to analyze the follow-up data and possible prognostic factors of CIS patients satisfying DIS MRI criteria. PATIENTS AND METHODS: We performed a retrospective, multicenter study across 2 Italian centers. Clinical, MRI, and laboratory assessments were performed according to real-life clinical workup.
RESULTS: Out of the 137 enrolled patients, during a median follow-up time of 3.1years, 116 (84.7%) converted to MS with the large majority (78.4%) of the converters developing MS within 1year. In multivariate analysis, baseline predictors of an earlier conversion were a cerebellar/brainstem CIS (HR 2.00, 95% CI: 1.3-3.0, p=0.001) and the presence of all the Barkhof-Tintore MRI criteria (HR 1.67, 95% CI: 1.1-2.6, p=0.028).
CONCLUSIONS: Patients with CIS and DIS are at very high risk of an early conversion to MS. The onset with cerebellar/brainstem symptoms and the evidence of a higher MRI lesion load at baseline are the strongest independent predictors of an early conversion to MS.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clinically isolated syndrome; Conversion; Dissemination in space; Dissemination in time; Magnetic resonance imaging; Multiple sclerosis

Mesh:

Year:  2017        PMID: 28716249     DOI: 10.1016/j.jns.2017.06.008

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

1.  2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes.

Authors:  Lorenzo Gaetani; Luca Prosperini; Andrea Mancini; Paolo Eusebi; Maria Chiara Cerri; Carlo Pozzilli; Paolo Calabresi; Paola Sarchielli; Massimiliano Di Filippo
Journal:  J Neurol       Date:  2018-09-08       Impact factor: 4.849

2.  Conversion of clinically isolated syndrome to multiple sclerosis: a prospective multi-center study in Eastern India.

Authors:  T K Banerjee; M Saha; E Ghosh; A Hazra; A Das; D Choudhury; S Ojha; A Haldar; A Mukherjee; S S Nandi; A Ghosh; A Mukherjee; A Chatterjee; A Datta; S Purakayastha
Journal:  Mult Scler J Exp Transl Clin       Date:  2019-05-13

3.  Predicting conversion from clinically isolated syndrome to multiple sclerosis-An imaging-based machine learning approach.

Authors:  Haike Zhang; Esther Alberts; Viola Pongratz; Mark Mühlau; Claus Zimmer; Benedikt Wiestler; Paul Eichinger
Journal:  Neuroimage Clin       Date:  2018-11-05       Impact factor: 4.881

Review 4.  Cerebellar and/or Brainstem Lesions Indicate Poor Prognosis in Multiple Sclerosis: A Systematic Review.

Authors:  Yuyuan Yang; Meng Wang; Lulu Xu; Meixiang Zhong; Yajuan Wang; Moxin Luan; Xingao Li; Xueping Zheng
Journal:  Front Neurol       Date:  2022-04-29       Impact factor: 4.003

Review 5.  Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations.

Authors:  Tamás Biernacki; Zsófia Kokas; Dániel Sandi; Judit Füvesi; Zsanett Fricska-Nagy; Péter Faragó; Tamás Zsigmond Kincses; Péter Klivényi; Krisztina Bencsik; László Vécsei
Journal:  Int J Mol Sci       Date:  2022-03-21       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.